FEB 11, 2016 8:11 AM PST

Implantable Device Shrinks Pancreatic Tumors, Spares Body

WRITTEN BY: Xuan Pham
Iontophoresis attacks pancreatic cancer better than IV delivery

To stop an aggressive, lethal killer known as pancreatic cancer, scientists have devised a way to deliver a toxic chemo cocktail straight to the cancer base. This new delivery mechanism obliterates pancreatic cancer cells, but spares other cells in the body.
 
Pancreatic cancer has one of the worst mortality rates of all cancer types, largely because the cancer spreads rapidly and is seldom detected in its early stages. While surgery to remove the diseased tissue is the most effective treatment against pancreatic cancer, doctors can only operate in about 15% of the time. Consequently, once diagnosed, only one in four patients survive past the one-year mark.
 
 
Recent research has shown success with a new combination chemotherapy regimen, known as FOLFIRINOX. Combining four potent cancer drugs in one (folinic acid, fluorouracil, irinotecan, and oxaliplatin), FOLFIRINOX extends patient survival by an additional four months, the longest improvement in survival in patients with advanced pancreatic cancer. But FOLFIRINOX is so toxic when given intravenously that very few patients can tolerate this chemotherapy.
 
Researchers at the University of North Carolina (UNC) at Chapel Hill hoped to extract the full utility of FOLFIRINOX by targeting it only to the diseased pancreas. To do this, they developed an “iontophoretic device” that was implanted directly onto pancreatic tumors in mice. The device uses electric currents to diffuse the drugs directly into the pancreas, sparing other tissues and organs in the body and reducing collateral damages of the drugs.

"It's an exciting approach because there is so little systemic toxicity that it leaves room to administer additional drugs against cancer cells that may have spread in the rest of the body. – Jen Jen Yeh, senior study lead, and associate professor of surgery and pharmacology in the UNC School of Medicine.

Compared to intravenous delivery of FOLFIRINOX, localized iontophoretic delivery was much more effective at reducing tumor growth in a mouse model. Tumor cell proliferation also decreased significantly.
 
The authors attribute the improvements to the ability of the iontophoretic device to deliver much higher concentrations of drug straight to the tumor base itself. Though the experiments were done in mice, the researchers hope to soon extend the treatments to patients whose tumors are inoperable.
 
“If this works in humans, we hope the device can be used as a plug-and-play approach to delivering the latest, most promising drug regimens for patients who have a dire need for new and better treatments,” says James D. Byrne, first author of the paper.
 
The study was published in the Proceedings of the National Academy of Sciences on February 8, 2016.       

Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 09, 2021
Cell & Molecular Biology
CRISPR-SNP Chip Finds Point Mutations in DNA Without PCR
APR 09, 2021
CRISPR-SNP Chip Finds Point Mutations in DNA Without PCR
Some diseases, like sickle-cell anemia and familial amyotrophic lateral sclerosis are due to errors in only a single let ...
APR 29, 2021
Clinical & Molecular DX
Can We Diagnose Disease Based on How "Sticky" Cells Are?
APR 29, 2021
Can We Diagnose Disease Based on How "Sticky" Cells Are?
How “sticky” cells are, or their viscosity, holds a wealth of information about their health and functionali ...
MAY 03, 2021
Health & Medicine
The Challenges and Advantages of Direct PCR Amplification
MAY 03, 2021
The Challenges and Advantages of Direct PCR Amplification
  Testing for COVID-19 continues to be one of the most important tools in the global fight to slow and reduce the i ...
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
AUG 03, 2021
Drug Discovery & Development
A pediatric-friendly drug to combat snail fever
AUG 03, 2021
A pediatric-friendly drug to combat snail fever
           Schistosomiasis, also known as Bilharzia or snail fever, is a disease  ...
AUG 31, 2021
Clinical & Molecular DX
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
AUG 31, 2021
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
Alzheimer's is a neurodegenerative disease that affects over 26 million worldwide and is associated with memory prob ...
Loading Comments...